China has unified the catalog of medicines covered by medical insurance across the country to ensure that all medicines in the catalog are placed under a unified management and payment policy.
This measure is driven not only by fairness but also aims to streamline the process of settling medical expenses where they are incurred, said Huang Xinyu, an official of the National Healthcare Security Administration, at a press conference on Thursday.
The official added that since its inception in 2018, the National Healthcare Security Administration has continuously made dynamic adjustments to the catalog of medicines covered by medical insurance, including adding over 700 new medicines to the list.
To date, the catalog has included about 3,900 kinds of medicines, covering both Western medicine and traditional Chinese medicine, accounting for over 90 percent of the total expenditure on medicine purchases in public hospitals, according to Huang.
Huang said the administration is also working to make medicines more affordable through multiple means, including negotiation. During the first two months of this year, medical insurance funds had paid over 15 billion yuan (about 2.11 billion U.S. dollars) for 397 kinds of medicines covered by price agreements, benefiting 39.5 million people.
Online reading or offline clubs? Young Chinese embrace both in digital era
China's current account surplus remains in reasonable range
Chinese companies retain 2nd place on Hurun Top 500
People visit Inner Mongolia Science and Technology Center
Ravens sign WR Qadir Ismail, the son of former NFL receiver Qadry Ismail
Xi Meets Cambodian Prime Minister
China to host World robotics conference
Beverage grading system launched in Shanghai
Liverpool confirms Arne Slot as Jurgen Klopp's replacement
China launches new Earth observation satellite for environmental monitoring
Mystery artist who erected signs comparing pothole
A Boeing 737 MAX arrives in Guangzhou, ending nearly 5